Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mohawk Industries, Inc. (MHK): After Being Bullish in 2014 Andreas Halvorsen Trims His Stake

As a new filing with the Securities and Exchange Commission showed, Tiger cub Andreas Halvorsen‘s Viking Global has cut its exposure to $11 billion flooring manufacturer Mohawk Industries, Inc. (NYSE:MHK). According to the filing, Viking now owns 4.03 million shares of the company, the passive stake amassing 5.5% of the company. Previously, Viking held some 5.68 million shares, as it revealed in its latest 13F filing.

Andreas Halvorsen

Mr. Halvorsen is one of the greatest Tiger cubs (former employees of Julian Robertson’s Tiger Management who launched their own funds). After founding Viking Global back in 1999 with two other former Tiger employees David Ott and Brian Olson, Viking managed to return almost 90% after fees in its first full year. As we have discussed in an earlier article, Viking’s flagship fund returned on average 19% per year, and more than a decade after its launch, Viking manages an equity portfolio worth over $24 billion divided across several industries, with a slight focus towards healthcare and services stocks.

Moreover, Viking’s 13F portfolio posted value-weighted average returns of 0.67% per month during the 2000-2012 period, which is well-above the S&P 500 total return of 0.30% per month. In addition, Viking’s top five picks, which are represented by Illumina, Inc. (NASDAQ:ILMN), Pioneer Natural Resources (NYSE:PXD), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Walgreen Company (NYSE:WAG), and Lowe’s Companies, Inc. (NYSE:LOW) in its latest 13F filing, managed to return on average 0.84% per month in the same period, which is up by more than six percentage points than the S&P 500 total return.

Mohawk Industries, Inc. (NYSE:MHK) has posted modest returns since added to Viking’s equity portfolio during the third quarter of 2013, gaining less than 10% since the end of 2013. However, Mr. Halvorsen has been bullish on the stock throughout 2014, as Viking boosted its stake from around 651,100 shares held initially. The position still amasses between 2% and 3% of the fund’s equity portfolio, which is why it should not be overlooked.

The company is engaged in manufacturing and distribution of carpets, rugs, ceramic tiles, laminate, wood and other types of flooring under several key brands. Mohawk Industries, Inc. (NYSE:MHK)’s stock posted a modest 2% gain over the last 52 weeks as the company reported declines in revenues and earnings. However, at the same time, the company has attracted the interest of investors, as our data show. Out of more than 180 funds that we track at Insider Monkey, in the previous round of 13F filings 55 investors reported long positions in Mohawk Industries as of the end of September, up from 53 funds in the previous quarter. In addition, the aggregate value of the stakes held by these funds went up by $595.7 million to $3.16 billion.

Aside from Mr. Halvorsen, who increased Viking’s stake in Mohawk Industries, Inc. (NYSE:MHK) by 25% during the third quarter of 2014, the company has also attracted the attention of Stephen Mandel of Lone Pine Capital. In this way, Lone Pine initiated a $416.6 million stake during the third quarter, which contains 3.09 million shares and represents 1.62% of the fund’s equity portfolio. At the same time, Doug Silverman and Alexander Klabin‘s Senator Investment Group almost doubled its position to 1.69 million shares.

In addition to a bullish sentiment from some big investors, Mohawk Industries, Inc. (NYSE:MHK) also has a mean ‘Buy’ rating from analysts, while its average target price amounts to over $162 per share. In addition, the company is expected to post significant revenue and earnings growth for the next two years.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!